Brief Articles Open Access
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Aug 21, 2009; 15(31): 3901-3907
Published online Aug 21, 2009. doi: 10.3748/wjg.15.3901
Different patterns of intestinal response to injury after arterial, venous or arteriovenous occlusion in rats
Francisco Javier Guzmán-de la Garza, Carlos Rodrigo Cámara-Lemarroy, Nancy Esthela Fernández-Garza, Department of Physiology, Autonomous University of Nuevo León, School of Medicine, Monterrey, Nuevo León 64460, México
Gabriela Alarcón-Galván, Pathologic Anatomy and Cytopathology Service, “José Eleuterio González” University Hospital, Monterrey, Nuevo León 64460, México
Paula Cordero-Pérez, Linda Elsa Muñoz-Espinosa, Liver Unit, Department of Internal Medicine, Autonomous University of Nuevo León, School of Medicine, Monterrey, Nuevo León 64460, México
Author contributions: Guzmán-de la Garza FJ designed the study; Cámara-Lemarroy CR and Guzmán-de la Garza FJ performed the research; Cordero-Pérez P and Alarcón-Galván G contributed morphological analytic tools for tissue samples; Cámara-Lemarroy CR, Muñoz-Espinosa LE and Fernández-Garza NE analyzed the data; and Cámara-Lemarroy CR wrote the paper.
Correspondence to: Carlos Rodrigo Cámara-Lemarroy, MD, Department of Physiology, School of Medicine, U.A.N.L, Av. Francisco I. Madero and Dr. Eduardo Aguirre Pequeño S/No., Col. Mitras Centro, Monterrey, Nuevo León 64460, México. crcamara83@hotmail.com
Telephone: +52-81-83294203
Fax: +52-81-83294203
Received: June 4, 2009
Revised: July 11, 2009
Accepted: July 18, 2009
Published online: August 21, 2009

Abstract

AIM: To investigate the differences in injury patterns caused by arterial, venous or arteriovenous mesenteric occlusion.

METHODS: Male Wistar rats were separated equally into four groups. Occlusion was performed by clamping the superior mesenteric artery (A), the mesenteric vein (V) or both (AV) for 30 min, followed by 60 min of reperfusion. A control group received sham surgery only. Intestinal sections were examined for histological damage and serum tumor necrosis factor-α (TNF-α), endothelin-1 (ET-1), P-selectin, antithrombin III (ATIII) and soluble intracellular adhesion molecule-1 (ICAM-1) concentrations were measured.

RESULTS: All groups showed significant mucosal injury compared to controls. Furthermore, mucosal injury was significantly more severe in the V and AV groups compared to the A group (3.6 ± 0.55, 3.4 ± 0.55 and 2 ± 0.71, respectively, P = 0.01). ICAM-1 was similarly elevated in all groups, with no significant differences between the groups. P-selectin levels were significantly elevated in the V and AV groups but not the A group (1.4 ± 0.5 ng/mL, 2.52 ± 0.9 ng/mL and 0.02 ± 0.01 ng/mL, respectively, P = 0.01) and ET-1 was significantly elevated in the A and V groups but not the AV group (0.32 ± 0.04 pg/mL, 0.36 ± 0.05 pg/mL and 0.29 ± 0.03 pg/mL, respectively, P = 0.01) compared to sham controls. ATIII levels were markedly depleted in the V and AV groups, but not in the A group (29.1 ± 5.2 pg/mL, 31.4 ± 21.8 pg/mL and 55.8 ± 35.6 pg/mL, respectively, P = 0.01), compared to controls. Serum TNF-α was significantly increased in all groups compared to sham controls (1.32 ± 0.87 ng/mL, 1.79 ± 0.20 ng/mL and 4.4 ± 0.69 ng/mL, for groups A, V and AV, respectively, P = 0.01), with higher values in the AV group.

CONCLUSION: Different patterns of response to ischemia/reperfusion are associated with venous, arterial or arteriovenous occlusion. Venous and arteriovenous occlusion was associated with the most severe alterations.

Key Words: Arterial occlusion, Rat, Intestine, Ischemia/reperfusion, Venous occlusion



INTRODUCTION

Acute mesenteric ischemic disease can be either arterial or venous in etiology. Acute arterial ischemia results from reduced blood flow caused by mesenteric artery thrombosis or embolism, leading to bowel necrosis and high mortality[1]. Mesenteric vein occlusion is usually due to thrombosis, is less common than arterial occlusion and carries a lesser risk of bowel necrosis and therefore reduced mortality[23]. Greater knowledge of the differences between these conditions would aid the search for therapeutic interventions, and also expand our understanding of ischemia/reperfusion (I/R) pathophysiology. This information would also be relevant for transplantation and aortic reconstruction procedures, which are invariably related to periods of I/R[4].

The intestine is very susceptible to ischemic injury. Ischemia causes mucosal damage through the production of substances like oxygen-derived free radicals, pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and the complement system[5]. The pattern of injury has been found to be different after experimental arterial or venous occlusion of the mesenteric circulation followed by reperfusion. Generally, the histological injury grade is thought to be greater after venous occlusion, even though energy metabolism is altered to a lesser extent than in arterial occlusion[6]. However, another study found that venous congestion alone could not cause reperfusion injury, while arterial occlusion could do so easily[7]. This issue could be resolved if the differences between the injury response to these two situations could be found.

During I/R, endothelial functions are altered, resulting in microcirculatory dysfunction which modulates mucosal integrity[8]. Endothelial injury and increased vascular permeability also occur[9]. The vascular endothelium regulates vascular tone, leukocyte adhesion and the coagulation cascade, among other factors. Endothelial function serum marker levels such as intracellular adhesion molecule-1 (ICAM-1), endothelin-1 (ET-1) and coagulation factors have also been found to be altered after I/R. One study showed that ET-1 modulates intestinal I/R injury in rats[10], while another showed that ICAM-1 is overexpressed, possibly contributing to injury by promoting leukocyte infiltration[11]. Another adhesion molecule, P-selectin, is also thought to modulate intestinal I/R injury, through complement deposition and leukocyte interaction[12]. Intestinal I/R also causes hemostatic alterations, namely coagulation induction, thrombin generation, and fibrin deposition, which correlate with the extent of injury[13].

In this study we evaluate the possibility that arterial, venous and arteriovenous occlusion, followed by reperfusion, might cause different types of response to I/R injury in the intestine. These differences were investigated by measuring ET-1, antithrombin III (ATIII), soluble ICAM-1 and P-selectin serum concentrations, soluble markers of endothelial function, as well as by measuring TNF-α, a cytokine that plays a central role in I/R injury.

MATERIALS AND METHODS
Animal procedures

Animal procedures were performed in accordance with the proper use and care of laboratory animals, approved by the ethics committee of our institution. Experiments were performed on 20 male Wistar rats weighing 200-250 g. Animals were maintained under standard conditions, such as stable room temperature (24 ± 3°C), a 12 h light/12 h dark cycle, and access to commercial rat pellets and water ad libitum.

Animal model

Briefly, after pentobarbital sodium anesthesia (Anestesal, Pfizer Inc, Mexico) (35 mg/kg, i.p), a midline laparotomy was performed, and the small intestine was externalized and wrapped in humid gauze. Animals were placed under a heating lamp in order to preserve core body temperature at (37°C). The cecum was occluded using a 2-0 nylon suture to prevent collateral blood flow, and ischemia was induced by obstructing either the superior mesenteric artery, the mesenteric vein before its union with the portal system, or both, with microvascular clamps for 30 min (ischemia), and removed to allow 60 min reperfusion. Immediately after clamping the mesenteric vessels, the intestines were returned to the peritoneal cavity where they remained for the entire duration of the procedure. Occlusion was confirmed by loss of pulsation and characteristic red dark coloring of the intestine in the venous group, or pale pink coloring and loss of pulsation in the arterial group.

Rats were divided in four groups (n = 5). The first group received only sham surgery (Sham), where laparotomy was performed but intestines were only manipulated but not made ischemic. Group A was subjected to arterial occlusion and reperfusion as described above. Group V was subjected to venous occlusion and reperfusion as described above. Group AV was subjected to both arterial and venous occlusion and reperfusion as described above.

Morphological examination

Immediately after concluding the reperfusion period, rats were sacrificed by exsanguination from the aorta and tissue samples were obtained and fixed in 10% neutral buffered formalin overnight. Samples were then embedded in paraffin, and 4 μm-thick sections were stained with hematoxylin and eosin (H/E) and examined under a light microscope by a blinded pathologist. The Chiu score of mucosal injury was used to evaluate the degree of histological damage[14]. The scale consists of values from 0 to 5, where 0 is normal mucosa; 1, development of sub epithelial (Gruenhagen’s) spaces; 2, extension of the sub-epithelial space with moderate epithelial lifting from the lamina propria; 3, extensive epithelial lifting with occasional denuded villi tips; 4, denuded villi with exposed lamina propria and dilated capillaries; and 5, disintegration of the lamina propria, hemorrhage, and ulceration.

Inflammatory cell infiltration

Under light microscopy, H/E stained tissue samples were analyzed for leukocyte infiltration by a blinded pathologist. The predominant type was recorded in both mucosa and muscular layers, and intensity of infiltration was quantified with a numerical scale with values from 0 to 3, where 0, no infiltration; 1, mild infiltration; 2, moderate infiltration and 3, severe infiltration. Two slides and five high power fields per slide were examined and averaged.

Serum levels of ET-1, ATIII, P-selectin, ICAM-1 and TNF-α

At the end of the reperfusion period 3 mL of blood was obtained from each rat and left to clot for serum acquisition. Serum levels of ET-1 were determined using a rat ET-1 EIA kit (Immuno-Biological Laboratories, Japan). Serum levels of ATIII were determined using a rat ATIII ELISA kit (GenWay Biotech, USA). Serum levels of soluble ICAM-1 were determined using a quantikine rat sICAM-1 ELISA kit (R & D Systems, USA). Serum levels of P-selectin were determined using a quantikine rat P-selectin ELISA kit (R & D Systems, USA). These were used as markers of endothelial function. Serum concentrations of TNF-α were determined using a rat TNF-α Elisa kit (PeproTech, Mexico).

Statistical analysis

SPSS 11.0 statistical software (SPSS Inc. Software, Chicago, Illinois, USA) was used to analyze data using one-way analysis of variance (ANOVA) and with the Tukey-Kramer post-hoc test so as to determine comparisons between the groups, and differences between the groups, respectively. The relationships between the variables studied were determined by the calculation of Pearson correlation coefficients. All values are expressed as mean ± SD and P < 0.05 was considered statistically significant.

RESULTS
Morphological examination

The sham group showed normal intestinal mucosa (Chiu score 0.2 ± 0.45). All occlusion groups had significantly higher injury scores compared to the sham group (Figure 1, P < 0.01). Groups V and AV had the highest injury scores (3.6 ± 0.55 and 3.4 ± 0.55, respectively), showing severe epithelial lifting and severe capillary congestion (Figure 1), with no difference observed between these two groups. However, both the AV and V groups had significantly higher scores compared to group A (2 ± 0.71, P < 0.01), which showed moderate lifting and very little congestion.

Figure 1
Figure 1 Histological findings (H & E) and injury scores. A: Arterial occlusion and reperfusion group; V: Venous occlusion and reperfusion group; AV: Both arterial and venous occlusion and reperfusion group. aP < 0.05 vs sham; bP < 0.01 vs sham; dP < 0.01 vs A.
Inflammatory cell infiltration

Compared to the sham group (1.2 ± 0.45), groups V and AV (2.6 ± 0.55 and 2.6 ± 0.55) both had a significantly higher leukocyte infiltration intensity (Figure 1, P < 0.05). Group A (2 ± 0.7) was not statistically different from either the V or sham group. The infiltrate type was similar in all groups, and was composed mostly of neutrophils, with few macrophages or lymphocytes observed.

Serum markers of endothelial function

The sham group had soluble P-selectin serum concentrations of 0.83 ± 0.47 ng/mL. In group A the levels remained barely detectable, and were not statistically different to the sham group (0.02 ± 0.01 ng/mL). Groups V and AV had significantly higher values compared to the sham group (1.4 ± 0.5 ng/mL and 2.52 ± 0.9 ng/mL, respectively, P < 0.01), with the latter being significantly higher than the former (P < 0.05, Figure 2). ATIII serum concentrations were significantly depleted in groups V and AV compared to the sham group (29.1 ± 5.2 pg/mL and 31.4 ± 21.8 pg/mL vs 85.3 ± 17.4 pg/mL, respectively, P < 0.01), while in group A they remained within the sham group range (55.8 ± 35.6 pg/mL). However, there was no difference between the V or AV groups (Figure 2). No difference was found between ET-1 levels in the sham and AV groups (0.23 ± 0.01 pg/mL vs 0.29 ± 0.03 pg/mL, respectively, Figure 2). Levels in both the A and V groups were significantly elevated compared to the sham group (0.32 ± 0.04 pg/mL and 0.36 ± 0.05 pg/mL, respectively, P < 0.01), with levels in the V group also being significantly higher that in that in the AV group, but not the A group. Finally, all groups had significantly elevated soluble ICAM-1 serum concentrations compared to the sham group (A: 569.2 ± 170.8 pg/mL, V: 529 ± 191.5 pg/mL and AV: 483.9 ± 41.6 pg/mL vs 194 ± 38.9 pg/mL, respectively, P < 0.01), but no differences were found between each of these three groups (Figure 2). In summary, venous and arteriovenous occlusion elevated P-selectin, and depleted ATIII, to a greater extent than arterial occlusion only. Venous and arterial occlusion, but not arteriovenous occlusion, elevated ET-1 levels compared to sham groups, with no differences between them. ICAM-1 levels were elevated in all groups compared to the sham group, with no differences between them.

Figure 2
Figure 2 Serum concentrations of endothelial function markers and TNF-α. A: ET-1 serum concentrations; B: ATIII serum concentrations; C: P-selectin serum concentrations; D: Serum levels of soluble ICAM-1; E: TNF-α serum concentrations. aP < 0.05 vs sham; bP < 0.01 vs sham; dP < 0.01 vs A; eP < 0.05 vs V; fP < 0.01 vs V.
TNF-α serum concentrations

The sham group had TNF-α serum concentrations of 0.11 ± 0.14 ng/mL. In groups A, V and AV the levels were significantly increased compared to sham controls (1.32 ± 0.87 ng/mL, 1.79 ± 0.20 ng/mL and 4.4 ± 0.69 ng/mL, respectively, P < 0.01, Figure 2). TNF-α serum concentrations were significantly higher in the AV group compared to both the A and V group, with no differences observed between these two groups.

Linear correlations between variables

Linear correlations were observed between the systemic concentrations of endothelial function markers, TNF-α and injury scores. These correlations are shown in Table 1. All the measured variables, except for ATIII, showed a significant positive correlation with the histological injury score. ATIII showed a significant negative correlation with the injury score (r = 0.608, P < 0.01). TNF-α was the variable most strongly correlated with injury score (r = 0.715, P < 0.01).

Table 1 Pearson’s correlation coefficient between the variables studied.
TNF-αET-1P-selectinICAM-1ATIII
Chiu Score0.715a0.714b0.552a0.608b-0.633a
TNF-αx0.260.646b0.337-0.534a
ET-1x-0.0150.655b-0.409
P-selectinx0.044-0.275
ICAM-1x-0.532a
DISCUSSION

Ricci et al[15] found greater mortality in rats after intestinal arterial versus arteriovenous occlusion. However, Yano et al[16] found that the degree of intestinal damage due to venous occlusion was greater than the damage resulting from both arteriovenous and arterial occlusion, with no difference between the latter two procedures. Greater intestinal hemorrhage has also been observed after venous occlusion compared with arterial occlusion[6]. Other studies confirmed these findings, showing that venous occlusion could induce intestinal injury as early as within 5 min, while arterial occlusion could not even at longer time periods[17]. Some of the molecular bases of these differences have been investigated. Venous congestion has been shown to induce increased levels of inflammatory cytokines, in a similar way to arterial occlusion[18]. However, in one I/R study, intestinal malonyldialdehyde levels (as an index of free radicals) were found to be higher in venous occlusion compared to arterial occlusion, despite no obvious difference in tissue injury[19]. In other organs, such as the kidney, renal vein occlusion has been found to induce a stronger inflammatory response (TNF-α, free radicals, but not ICAM-1), neutrophilic infiltration, and greater functional damage, compared to arterial occlusion[20]. In our study, I/R due to venous occlusion was shown to cause greater damage to the intestinal mucosa than arterial occlusion alone, in agreement with the previous studies. However, we found no difference between the type or the intensity of injury between venous and arteriovenous occlusion. Arterial occlusion caused limited but significant histological damage and was associated with little leukocyte infiltration. The pro-inflammatory cytokine TNF-α is one of the main orchestrators of the inflammatory response and a key mediator of injury during I/R[21]. In our study, TNF-α levels were significantly elevated after all three occlusion methods, with the highest levels observed in the arteriovenous occlusion group. TNF-α concentrations were strongly correlated to injury intensity.

Intestinal I/R affects the microvasculature, endothelial cells, and endothelial cell function[8]. ET is a vasoactive substance which induces intense vasoconstriction of blood vessels, and its activation is thought to play an important part in the development of these microvascular changes[22]. ET-1 participates in intestinal I/R injury by modulating leukotriene production[10]. Additionally, it has been demonstrated that ET-1 is involved mainly in post-reperfusion induced vasospasm and damage, and ET receptor antagonists are able to protect against mucosal injury[23]. In agreement with previous reports, we found that I/R due to arterial occlusion induces elevations in ET-1 levels, and further, we demonstrated that venous occlusion has a similar outcome, although there was a tendency for higher levels in the venous occlusion group. Surprisingly, ET-1 elevation was not present when both arterial and venous occlusion was performed simultaneously. Other factors capable of explaining this result might be at play. It is known that reductions in perfusion pressure during mesenteric ischemia cause diminished arteriolar resistance and vasodilation as a compensatory mechanism[24]. While venous occlusion alone causes severe congestion and increased intravascular pressure, arterial occlusion alone might only cause reduced inflow perfusion with normal outflow. Supporting this idea, Tsunada et al[18] reported a more pronounced reduction of blood flow and increased subsequent flow recovery after reperfusion with arterial occlusion, compared to venous occlusion. We speculate that arteriovenous occlusion might balance inflow and outflow alterations, resulting in intravascular pressure and tone equilibrium, possibly explaining the absence of ET-1 activation which we observed. Further experiments are required to assess this possibility and the role of ET-1 in regulating post-ischemic vascular tone.

P-selectin is an adhesion molecule which modulates endothelial-leukocyte interactions. During intestinal I/R, P-selectin mRNA expression is upregulated in the microvascular endothelium[25] and P-selectin immunoreactivity is increased in the intestinal mucosa[26]. I/R studies have shown that P-selectin blockade or genetic deficiency result in diminished intestinal mucosa damage after I/R in rodent models, further supporting the idea that P-selectin participates in the pathophysiology of I/R injury[2728]. In our study, I/R in the arteriovenous occlusion group caused higher elevations of soluble P-selectin serum concentrations than in the venous occlusion group. Moreover, arterial occlusion was unable to alter these values compared to the sham group. P-selectin levels were also found to be correlated to histological injury scores.

The coagulation cascade is promoted by I/R[13]. ATIII is an endogenous anticoagulation molecule produced in lung, liver and endothelium which limits thrombin formation. Thrombin activation and the formation of thrombin-antithrombin complex is increased after intestinal I/R, contributing to cytokine production and inflammatory injury[29]. Furthermore, these alterations would theoretically result in endogenous ATIII depletion. One rodent study found that ATIII levels were indeed depleted after intestinal I/R, and that they were restored by protective therapy[30]. Additionally, ATIII administration can protect the intestinal mucosa against I/R injury[31]. We found that I/R due to both venous and arteriovenous occlusion caused ATIII depletion whereas arterial occlusion alone did not. In our study, a negative correlation between ATIII levels and injury scores was observed, suggesting that depleted ATIII levels are indeed reflective of damage intensity. A possible explanation for our results is that the microvascular congestion and venous stasis caused by the venous occlusion component promotes the coagulation cascade to a greater extent than the arterial component during ischemia and reperfusion. Indeed, temporal and histological differences have been found to exist between thrombus generation in arterial and venous endothelium[32]. While stasis seems to be a more important factor in veins, impaired laminar flow and plaque formation seem to be essential for arterial thrombus generation[33]. Furthermore, studies have shown that decreased levels of ATIII after major surgery can predict higher complication and mortality rates[34]. Therefore, the differences in ATIII depletion between arterial or venous mesenteric ischemia might be of clinical relevance. The physiopathological consequences of these results warrant further investigation.

ICAM-1 is another adhesion molecule that mediates leukocyte reactivity and adhesion to endothelium. Intestinal I/R is also associated with an upregulation of ICAM-1 and subsequent leukocyte infiltration[35]. Systemic ICAM-1 activity is also upregulated, possibly contributing to multisystem failure and remote organ injury[11]. Serum levels of ICAM-1 have been shown to be markedly elevated after intestinal I/R, and low serum concentrations are associated with beneficial outcomes after the administration of protective agents[36]. The inhibition of ICAM-1 with monoclonal antibodies is able to reduce the intensity of the functional and morphological alterations in the intestine subjected to I/R[3738]. In our study, we found that soluble ICAM-1 serum concentrations were elevated by intestinal I/R, in agreement with the previous reports. However, there was no difference between any of the occlusion methods employed, suggesting that soluble ICAM-1 is non-specifically elevated in arterial, venous or arteriovenous I/R.

In conclusion, we showed that a different pattern of response to I/R characterize different forms of mesenteric occlusion methods. Venous occlusion seems to cause more severe tissue damage and changes in P-selectin and ATIII depletion compared to arterial occlusion. This suggests that these molecules are sensitive to changes in the intensity of the histological injury and therefore might be partly responsible for some of the pathophysiological differences between venous and arterial occlusion. Arteriovenous occlusion showed greater tissue damage and TNF-α levels compared to arterial occlusion alone, but only differences in P-selectin and ET-1 were found between them. Finally, arterial occlusion was related to the least severe changes compared to controls, and ICAM-1 values were not different between the different I/R groups.

We discussed the possibility of these differences being dependent on local microvascular factors, but since serum concentrations are indicative of the systemic state, the explanation could lie in differences in the systemic consequences of the occlusion methods employed. Studies on the local and remote tissue expression of these molecules would be helpful in clarifying these issues. However, our results confirm that there are differences in the inflammatory responses associated with venous, arterial or arteriovenous occlusion that could partly explain the molecular bases of the clinical differences between these conditions.

COMMENTS
Background

Intestinal ischemia can occur when blood flow from the mesenteric vasculature is obstructed. Obstructions can be embolic, atherosclerotic or vasospastic in etiology. Mesenteric veins or arteries can be affected. Ischemia and reperfusion also takes place in transplant procedures and states of hypoperfusion (shock). The pathophysiological differences between venous, arterial or total ischemia of the intestine are not fully understood. In this study, the aim was to investigate these differences using a rat model.

Research frontiers

Ischemia/reperfusion is an important topic of research. The molecular mediators responsible for ischemia/reperfusion injury could be modulated to improve transplantation outcomes.

Innovations and breakthroughs

In this study, it is demonstrated that venous, arterial or arteriovenous occlusion followed by reperfusion, cause different patterns of injury and serum elevations of inflammatory markers.

Applications

To understand the pathophysiological bases of ischemia/reperfusion injury could lead to novel treatments, specifically tailored for conditions of venous, arterial or total ischemia.

Peer review

This is a very interesting study which examines changes in rat intestinal histology and inflammatory serum cytokine markers subsequent to arterial, venous or concomitant arterial and venous occlusion and reperfusion. The authors demonstrated the differences in injury patterns caused by arterial, venous or arteriovenous mesenteric occlusion. This study is well-investigated and has a novel finding.

Footnotes

Peer reviewers: Yuji Naito, Professor, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan; Jay Pravda, MD, Inflammatory Disease Research Center, Gainesville, Florida, 32614-2181, United States

References
1.  Berland T, Oldenburg WA. Acute mesenteric ischemia. Curr Gastroenterol Rep. 2008;10:341-346.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Menon NJ, Amin AM, Mohammed A, Hamilton G. Acute mesenteric ischaemia. Acta Chir Belg. 2005;105:344-354.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Sreenarasimhaiah J. Diagnosis and management of intestinal ischaemic disorders. BMJ. 2003;326:1372-1376.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Hauge EM, Balling E, Hartmund T, Hjortdal VE. Secondary ischemia caused by venous or arterial occlusion shows differential effects on myocutaneous island flap survival and muscle ATP levels. Plast Reconstr Surg. 1997;99:825-833.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Cerqueira NF, Hussni CA, Yoshida WB. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras. 2005;20:336-343.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Kimura M, Kataoka M, Kuwabara Y, Sato A, Sugiura M, Fujii Y. Real-time energy metabolism of intestine during arterial versus venous occlusion in the rat. J Gastroenterol. 2003;38:849-853.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Park PO, Haglund U, Bulkley GB, Fält K. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery. 1990;107:574-580.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Boros M. Microcirculatory dysfunction during intestinal ischemia-reperfusion. Acta Physiol Hung. 2003;90:263-279.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Nosál'ová V, Sotníková R, Mihalová D, Navarová J. Gut and vessel alterations induced by mesenteric ischaemia/reperfusion in rats. Cent Eur J Public Health. 2004;12 Suppl:S70-S72.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Anadol AZ, Bayram O, Dursun A, Ercan S. Role of endogenous endothelin peptides in intestinal ischemia-reperfusion injury in rats. Prostaglandins Leukot Essent Fatty Acids. 1998;59:279-283.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Olanders K, Sun Z, Börjesson A, Dib M, Andersson E, Lasson A, Ohlsson T, Andersson R. The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats. Shock. 2002;18:86-92.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Gibbs SA, Weiser MR, Kobzik L, Valeri CR, Shepro D, Hechtman HB. P-selectin mediates intestinal ischemic injury by enhancing complement deposition. Surgery. 1996;119:652-656.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Schoots IG, Levi M, van Vliet AK, Maas AM, Roossink EH, van Gulik TM. Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med. 2004;32:1375-1383.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101:478-483.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Ricci JL, Sloviter HA, Ziegler MM. Intestinal ischemia: reduction of mortality utilizing intraluminal perfluorochemical. Am J Surg. 1985;149:84-90.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Yano K, Hata Y, Matsuka K, Ito O, Matsuda H. Time limits for intestinal ischemia and congestion: an experimental study in rats. Ann Plast Surg. 1994;32:310-314.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Tsuchida Y, Aoki N, Fukuda O, Nakano M, Igarashi H. Changes in hemodynamics in jejunal flaps of rabbits due to ischemia, venous congestion, and reperfusion as measured by means of colored microspheres. Plast Reconstr Surg. 1998;101:147-154.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Wu B, Fujise T, Iwakiri R, Ootani A, Amemori S, Tsunada S, Toda S, Fujimoto K. Venous congestion induces mucosal apoptosis via tumor necrosis factor-alpha-mediated cell death in the rat small intestine. J Gastroenterol. 2004;39:1056-1062.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Akcakaya A, Alimoglu O, Sahin M, Abbasoglu SD. Ischemia-reperfusion injury following superior mesenteric artery occlusion and strangulation obstruction. J Surg Res. 2002;108:39-43.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Park Y, Hirose R, Dang K, Xu F, Behrends M, Tan V, Roberts JP, Niemann CU. Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model. Surgery. 2008;143:243-251.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Pascher A, Klupp J. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors? BioDrugs. 2005;19:211-231.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Kaszaki J, Wolfárd A, Szalay L, Boros M. Pathophysiology of ischemia-reperfusion injury. Transplant Proc. 2006;38:826-828.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Oktar BK, Gülpinar MA, Bozkurt A, Ghandour S, Cetinel S, Moini H, Yeğen BC, Bilsel S, Granger DN, Kurtel H. Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: role of blood flow. Am J Physiol Gastrointest Liver Physiol. 2002;282:G647-G655.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. Arch Intern Med. 2004;164:1054-1062.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Eppihimer MJ, Russell J, Anderson DC, Epstein CJ, Laroux S, Granger DN. Modulation of P-selectin expression in the postischemic intestinal microvasculature. Am J Physiol. 1997;273:G1326-G1332.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Marzocco S, Di Paola R, Autore G, Mazzon E, Pinto A, Caputi AP, Thiemermann C, Cuzzocrea S. Calpain inhibitor I reduces intestinal ischemia-reperfusion injury in the rat. Shock. 2004;21:38-44.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Carmody IC, Meng L, Shen XD, Anselmo D, Gao F, Ke B, Ma JP, Kupiec-Weglinski JW, McDiarmid SV, Busuttil RW. P-selectin knockout mice have improved outcomes with both warm ischemia and small bowel transplantation. Transplant Proc. 2004;36:263-264.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Farmer DG, Anselmo D, Da Shen X, Ke B, Carmody IC, Gao F, Lassman C, McDiarmid SV, Shaw G, Busuttil RW. Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation. 2005;80:828-835.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Tsuboi H, Naito Y, Katada K, Takagi T, Handa O, Kokura S, Ichikawa H, Yoshida N, Tsukada M, Yoshikawa T. Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia-reperfusion injury in rats. Am J Physiol Gastrointest Liver Physiol. 2007;292:G678-G683.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Sun Z, Olanders K, Lasson A, Dib M, Annborn M, Andersson K, Wang X, Andersson R. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1. J Surg Res. 2002;105:220-233.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Ozden A, Tetik C, Bilgihan A, Calli N, Bostanci B, Yis O, Düzcan E. Antithrombin III prevents 60 min warm intestinal ischemia reperfusion injury in rats. Res Exp Med (Berl). 1999;198:237-246.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Hassantash SA, Bikdeli B, Kalantarian S, Sadeghian M, Afshar H. Pathophysiology of aortocoronary saphenous vein bypass graft disease. Asian Cardiovasc Thorac Ann. 2008;16:331-336.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Lowe GD. Virchow's triad revisited: abnormal flow. Pathophysiol Haemost Thromb. 2003;33:455-457.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Wilson RF, Farag A, Mammen EF, Fujii Y. Sepsis and antithrombin III, prekallikrein, and fibronectin levels in surgical patients. Am Surg. 1989;55:450-456.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Xia G, Martin AE, Besner GE. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg. 2003;38:434-439.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Vejchapipat P, Leawhiran N, Poomsawat S, Theamboonlers A, Chittmittrapap S, Poovorawan Y. Amelioration of intestinal reperfusion injury by moderate hypothermia is associated with serum sICAM-1 levels. J Surg Res. 2006;130:152-157.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Ilhan H, Alatas O, Tokar B, çOlak O, Paşaoĝlu O, Koku N. Effects of the anti-ICAM-1 monoclonal antibody, allopurinol, and methylene blue on intestinal reperfusion injury. J Pediatr Surg. 2003;38:1591-1595.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Sun Z, Wang X, Lasson A, Böjesson A, Annborn M, Andersson R. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. Scand J Gastroenterol. 2001;36:55-65.  [PubMed]  [DOI]  [Cited in This Article: ]